Men’s Health Update

Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers

Publish Date October 22, 2021

A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.

FDA Approves Moderna, J&J Booster Shots, Backs Mix ‘n’ Match Vaccines

Publish Date October 22, 2021

Agency’s decision is one of the last steps toward a full rollout of booster shots to eligible Americans

Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19

Publish Date October 22, 2021

Likelihood of improvement in organ support-free days low in critically ill adults with COVID-19 receiving convalescent plasma

MRI Results Might Permit Sparing of the Transitional Zone During Prostate Biopsy

Publish Date October 21, 2021

Compared with peripheral zone prostate cancers, transitional zone cancers are less prevalent and tend to have more favorable pathological characteristics.

Proteins May Predict Lethal Prostate Cancer in African-American Patients

Publish Date October 14, 2021

The proteins were only predictive for African-American patients, not European-American patients.

Flu Cases Already Up 23 Percent This Season: Walgreens

Publish Date October 20, 2021

Significant increase shown by the company’s analysis of its own data reflects the historically low levels of flu last year

Botulinum Toxin’s Efficacy for Post-Prostatectomy OAB Varies by Subtype

Publish Date October 20, 2021

Long-term post-prostatectomy urinary incontinence affects 3% to 10% of patients.

FDA Expected to Allow Mix ‘n’ Match COVID-19 Vaccines

Publish Date October 20, 2021

Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine

Myocarditis Reported After BNT162b2 Vaccination in Israel

Publish Date October 20, 2021

Estimated incidence highest among males 16 to 29 years; second study shows highest standardized incidence ratio for males 16 to 19 years

PSA Screening Recommendation Tied to Decrease in Prostate Cancer-Specific Survival

Publish Date October 19, 2021

The 3-year prostate cancer-specific survival decreased significantly for insured patients.